Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Studies show that 8-9% of patients experience diarrhea, while nausea remains the most common complaint
Any individual considering retatrutide should do so only within the context of an approved clinical trial or under direct medical supervision
Everyones starting point is different
Those options may help, but the first question should be: Is the current GLP-1 dose moving faster than the body can tolerate
If any unexpected or concerning changes occur, use should be paused, and medical advice sought
Patients should be monitored for signs of dehydration, electrolyte abnormalities, and nutritional deficiencies, particularly if gastrointestinal side effects limit intake
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
